Previous Article | Next Article ![]()
J Virol, February 1998, p. 1165-1170, Vol. 72, No. 2
Laboratory of Receptor Biology and Gene
Expression1 and
Laboratory of
Chemoprevention,2 Division of Basic Sciences,
National Cancer Institute, Bethesda, Maryland 20892
Received 10 June 1997/Accepted 22 October 1997
Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiologic
agent for adult T-cell leukemia. HTLV-1 transforms lymphocytes, and
there is increasing evidence that the virus-encoded protein, Tax, plays
a primary role in viral transformation. We have shown that wild-type
p53 in HTLV-1-transformed cells is stabilized. This study was initiated
to directly analyze whether the p53 in HTLV-1-transformed cell lines
was transcriptionally active and to identify the viral gene product
responsible for stabilization and inactivation. Transfection
experiments using a p53-responsive reporter plasmid and
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inhibition of p53 Transactivation Function by the
Human T-Cell Lymphotropic Virus Type 1 Tax Protein


-irradiation studies demonstrate that the wild-type p53 in
HTLV-1-transformed cell lines is not fully active. Further, we
demonstrate that the HTLV-1-transforming protein, Tax, stabilizes
and inactivates p53 function. Cotransfection of Tax with p53 results in
a greater than 10-fold reduction in p53 transcription activity.
Using Gal4-p53 fusion proteins, we demonstrate that Tax
inhibition of p53 transactivation function is independent of
sequence-specific DNA binding. Moreover, Tax inhibits p53 function by
interfering with the activity of the N-terminal activation domain
(amino acids 1 to 52). We conclude that Tax is involved in the
inactivation of p53 function and stabilization of p53 in HTLV-1-infected cells. The functional interference of p53 function by
Tax may be important for transformation and leukemogenesis.
*
Corresponding author. Mailing address: Laboratory of
Receptor Biology and Gene Expression, Division of Basic Sciences,
National Cancer Institute, 41 Library Dr., 41/B403, Bethesda, MD
20892. Phone: (301) 496-0986. Fax: (301) 496-4951. E-mail:
bradyj{at}dce41.nci.nih.gov.
Present address: Department of Biochemistry, Ajou University of
Medicine, Su Won 442-749, Korea.
Present address: Institut für Zellbiologie, Abteilung
Molekularbiologie, Eberhard-Karls-Universitat Tübingen,
72076 Tübingen, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|